Trial Profile
A Bioequivalence study of DS-5058b (immediate-release tablet) and oxycodone hydrochloride hydrate in healthy Japanese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 07 Sep 2018 Status changed from active, no longer recruiting to completed.
- 20 Apr 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 05 Dec 2017 New trial record